Mirum Pharmaceuticals (MIRM) Net Equity Issued and Repurchased (2018 - 2026)
Mirum Pharmaceuticals' Net Equity Issued and Repurchased was $7.76 million in Q3 2026, down 51.8% from $16.1 million a year earlier and down 41.9% from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Mirum Pharmaceuticals' Net Equity Issued and Repurchased was $300.21 million through Sep 30, 2026, up 722.9% year-over-year; for FY2025, it was $40.14 million, up 126.8% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $17.7 million in FY2024 (-92.2%), $227.15 million in FY2023 (+98.1%), $114.64 million in FY2022 and $9.01 million in FY2021 (-93.2%).
- The Q3 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q1 2025.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in six of the last seven quarters, with growth averaging 141.9%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q2 2022 (growth of 576.4%); the worst was Q4 2021 (a decline of 99.1%).
- Per Business Quant data, MIRM's Net Equity Issued and Repurchased in the three quarters before Q3 2026 was $13.37 million (Q2 2026), $270.08 million (Q1 2026) and $9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Mirum Pharmaceuticals | 6.16 Bn | 4.58 Bn | 150.55 Mn | 7.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.76 Mn |
| Jun 30, 2026 | 13.37 Mn |
| Mar 31, 2026 | 270.08 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 16.10 Mn |
| Jun 30, 2025 | 8.69 Mn |
| Mar 31, 2025 | 6.36 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 7.29 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Sep 30, 2023 | 207.13 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 87.74 Mn |
| Jun 30, 2022 | 6.35 Mn |
| Mar 31, 2022 | 18.86 Mn |
| Dec 31, 2021 | 735,000.00 |
API Access
Mirum Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();